News
Arvinas and Pfizer have filed for U.S. Food and Drug Administration approval of their proposed breast-cancer drug vepdegestrant in certain patients with estrogen-receptor mutations.
2d
SurvivorNet on MSNTargeted Drug Tagrisso Leads To More Tumor Shrinkage For Lung Cancer Patients With EGFR Mutation: Unpacking The New DataPatients with stage II and IIIB non-small cell lung cancer (NSCLC) with an EGFR mutation had better outcomes when treated ...
When the workload on the heart increases, the ventricular wall may thicken too, known as cardiac hypertrophy. This is an adaptive response that reduces pressure on the heart and maintains the activity ...
In addition to buzzy ingredients like exosomes and PDRN, growth factor serums are another type of futuristic formula on the rise. Growth factors are naturally occurring proteins that are produced ...
There are old generics like Neulasta ... a slowdown in cost growth and an increase in the share of high-margin products. An additional factor will be a reduction in the effective tax rate.
a biosimilar to Neulasta ® (pegfilgrastim), expands the company's portfolio of FDA-approved products and accelerates Accord BioPharma's growth in the biosimilar industry. By acquiring UDENYCA ...
Jobevne is a vascular endothelial growth factor inhibitor that binds with ... which also includes Ogivri (Trastuzumab-dkst) and Fulphila (Pegfilgrastim-jmdb). The company also markets bevacizumab ...
Pegfilgrastim is an immunostimulant colony-stimulating factor that promotes the development and differentiation of mature and functionally active neutrophils from precursor cells in bone marrow.
Nerve growth factor is a protein that stimulates the development of neurons. It is also a powerful driver of pain in animals and humans, and is released by cells from injured or diseased tissue.
However, the solution you've been searching for might be as simple as one of the best growth factor serums. Often considered as a gentler alternative to retinol, these unique formulas comprise ...
UDENYCA® is the only pegfilgrastim brand approved in the ... INDICATIONUDENYCA® is a leukocyte growth factor indicated to: Decrease the incidence of infection, as manifested by febrile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results